Plascencia ÁNI, Rayo MD

Idioma: Español
Referencias bibliográficas: 29
Paginas: 128-132
Archivo PDF: 83.98 Kb.

FRAGMENTO

El uso terapéutico de la toxina botulínica inició en los años 80 con el tratamiento del estrabismo y posteriormente del blefarospasmo y otras distonías focales.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Dressler D. Botulin Toxin therapy. Stuttgart: Georg Thieme Verlag; 2000.

2. Muthane UB, Panikar JN. Botulinum toxins: Pharmacology and its current therapeutic evidence for use. Neurol India 2003; 51: 455-60.

3. Lowe N, Campanati A, Bodokh I, et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol 2004; 151: 1115-22.

4. Jongerius PH, van de Hoogen FJ, van Limbeek J, Gabreels FJ, van Huls K, Rotteveel JJ. Effect of botulism toxin in the treatment of drooling: A controlled clinical trial. Pediatrics 2004; 164: 620-7.

5. Naumann M, Jost W. Botulinum toxin treatment of secretory disorders. Mov Disord 2004; 19(Suppl. 8): S137-S141

6. Suskin DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002; 112: 73-81.

7. Lipp A, Trottemberg T, Schink T, Kupsch A, Arnold G. A randomized trial of botulinum toxin A treatment for drooling. Neurology 2003; 61: 1279- 81.

8. Naumman M, Zellner M, Toyka KV, Reiners K. Treatment of gustatory sweating with botulinum toxin. Ann Neurol 1997; 42: 973-5.

9. Restivo DA, Lanza S, Patti F. Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A. Neurology 2002; 59: 1971-3.

10. Boroojerdi B, Febert A, Schwarz M, Herath H, Noth J. Botulinum toxin treatment for synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1998; 65: 493-502.

11. Montoya JF, Riddell CE, Caesar R, Hague S. Treatment of gustatory hyperlacrimation (crocodile Tears) with injection of botulinum toxin into the lacrimal gland. Eye 2002; 16: 705-9.

12. Kreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol 2004; 22: 40-4.

13. Amir M, Arisch A, Weinstein Y, Pfeffer M, Levy Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): Preliminary results. Isr J Psychiatry Relat Sci 2000; 37: 25-31.

14. Munchau A, Bhatia KP. Uses of Botulinum toxin injection in medicine today. BMJ 2000; 320: 161-5.

15. Naumann M, Hamm H, Kinkelin I, Reiners K. Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions. Euro J Neurol 1999; 6: S111-115.

16. Naver H, Anquilonium SM. The treatment of focal hyperhidrosis with botulinum toxin. Euro J Neurol 1997; 4: S75-79.

17. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70(19): 1707-14.

18. Van de Heyning PH, Marquet JF, Creten WL. Drooling in children with cerebral palsy. Acta Otorhinolaryngol Belg 1980; 34: 691-705.

19. Bateson MC, Gibberd FB, Wilson RSE. Salivary symptoms in Parkinson’s disease. Arch Neurol 1973; 14: 13-22.

20. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose ranging study. Arch Pediatr Adolesc Med 2000; 154: 1214-8.

21. Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreels FJ, van Hulst K, van den Hoogen FJ. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 2004; 63: 1371-5.

22. Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreels FJ, vanHulst K, Rotteveel JJ. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 2004; 114: 620-7.

23. Lal D, Hotaling A. Drooling. Curr Op Otolaringol Head Neck Surg 2006; 14(6): 381-6.

24. Crydale WS, White A. Submandibular duct relation for drooling: a 10 year experience with 194 patients. Otolaryngol Head Surg 1989; 101: 87-92.

25. Lipp A, Trottenberg T, Schink T, et al. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003; 61: 1279-81.

26. Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology 2004; 62: 37-40.

27. Savarese R, Diamond M, Elovic E, Millis SR. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhoea in children with cerebral palsy. Am J Phys Med Rehabil 2004; 3: 304-11.

28. Hassin-Baer S, Scheuer E, Buchman AS, Jacobson I, Ben-Zeev B. Botulinum toxin injections for children with excessive drooling. J Child Neurol 2005; 20: 120-3.

29. Nauman M, Gronseth GS, So Y, Argoff CE, Childers MK, Dykstra DD, Jabbari B, Kaufmann HC, Schurch B, Silberstein SD, Simpson MD. Neurology 2008; 70: 1707-14.